Abivax S.A. - ABVX
About Gravity Analytica
Recent News
- 09.12.2025 - Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
- 09.12.2025 - Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
- 09.08.2025 - Abivax Presents First Half 2025 Financial Results
- 09.08.2025 - Abivax Presents First Half 2025 Financial Results
- 08.11.2025 - 2025 Half-Year Business and Financial Report (as of June 30, 2025)
- 08.11.2025 - 2025 Half-Year Business and Financial Report (as of June 30, 2025)
- 07.28.2025 - Abivax Announces Closing of $747.5 Million Public Offering
- 07.28.2025 - Abivax Announces Closing of $747.5 Million Public Offering
- 07.25.2025 - Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)
- 07.25.2025 - Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)